Table 1 Characteristics of 53 patients treated with the triplet chemotherapy regimen
Median age (range) (y) | 52 (23–74) |
Male/female [number (%)] | 29 (55)/24 (45) |
ECOG performance status [number (%)] | |
 0 | 7 (13) |
 1 | 35 (66) |
 2 | 11 (21) |
Primary tumor site [number (%)] | |
 Colon | 23 (40) |
 Rectosigmoid | 21 (36) |
 Rectum | 9(15) |
Prior surgery for primary tumor [number (%)] | 29 (55) |
Prior adjuvant chemotherapy [number (%)] | 6 (11) |
Prior radiotherapy [number (%)] | 0 |
Number of metastasis sites [number (%)] | |
 Single | 22 (42) |
 Multiple sites | 31 (58) |
Metastasis sites [number (%)] | |
 Liver | 35 (66.0) |
 Lung | 22 (41.5) |
 Lymph nodes | 21 (39.6) |
 Peritoneum | 14 (26.4) |
K-ras [number (%)] | |
 Wild-type | 20 (37.0) |
 Mutated | 20 (37.0) |
 Unknown | 13 (26.0) |